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Abstract
The Drosophila MSL complex mediates dosage compensation by increasing transcription of the single X chromosome in
males approximately two-fold. This is accomplished through recognition of the X chromosome and subsequent acetylation
of histone H4K16 on X-linked genes. Initial binding to the X is thought to occur at ‘‘entry sites’’ that contain a consensus
sequence motif (‘‘MSL recognition element’’ or MRE). However, this motif is only ,2 fold enriched on X, and only a fraction
of the motifs on X are initially targeted. Here we ask whether chromatin context could distinguish between utilized and
non-utilized copies of the motif, by comparing their relative enrichment for histone modifications and chromosomal
proteins mapped in the modENCODE project. Through a comparative analysis of the chromatin features in male S2 cells
(which contain MSL complex) and female Kc cells (which lack the complex), we find that the presence of active chromatin
modifications, together with an elevated local GC content in the surrounding sequences, has strong predictive value for
functional MSL entry sites, independent of MSL binding. We tested these sites for function in Kc cells by RNAi knockdown of
Sxl, resulting in induction of MSL complex. We show that ectopic MSL expression in Kc cells leads to H4K16 acetylation
around these sites and a relative increase in X chromosome transcription. Collectively, our results support a model in which
a pre-existing active chromatin environment, coincident with H3K36me3, contributes to MSL entry site selection. The
consequences of MSL targeting of the male X chromosome include increase in nucleosome lability, enrichment for H4K16
acetylation and JIL-1 kinase, and depletion of linker histone H1 on active X-linked genes. Our analysis can serve as a model
for identifying chromatin and local sequence features that may contribute to selection of functional protein binding sites in
the genome.
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Introduction
In Drosophila, Male Specific Lethal (MSL) complex binds to the
single male X chromosome to increase transcription approxi-
mately two-fold, in order to equalize the output of both female X
chromosomes [2–4]. We have proposed that MSL complex locates
its target binding sites using a two-step mechanism [5]. First, the
complex distinguishes X from autosomes by binding a subset of
200–300 sites on X known as ‘‘chromatin entry sites’’ (CES) [6–8]
or ‘‘high affinity sites’’ (HAS) [9,10]. Recognition of CES is a
sequence-dependent step, as these sites share a GA-rich motif
[8,10] designated the ‘‘MSL recognition element’’, or MRE,
whose function has been demonstrated by site-directed mutagen-
esis [8]. In contrast, the second targeting step lacks a consensus
sequence but is strongly linked to transcription [11–14], with the
complex locating active genes on the same chromosome [15].
CES were first identified in msl3 mutant embryos, in which the
initial, sequence-specific step of MSL binding occurs but the
second, sequence-independent step does not [7,8]. The MRE
sequence motif was discovered based on the first 150 mapped CES
(Figure 1A). CES function was tested in transgenes for the ability
to attract MSL complex to autosomal insertion sites, and found to
PLoS Genetics | www.plosgenetics.org 1 April 2012 | Volume 8 | Issue 4 | e1002646be dependent upon the intact MRE motif [8]. 150 is likely an
underestimate of the total number of CES and functional MREs
on X, as subsequent analysis of high occupancy MSL binding sites
in wild type cells has revealed 309 peaks containing 379 MREs [8].
However, a conservative set of 150 should be sufficient to test for
predictive features.
The MRE motif is only modestly enriched on the X
chromosome compared to the autosomes. At a stringency where
137 of 150 CES contain the consensus motif (p-value of 10
25),
there is a 1.8 fold higher MRE density on X compared to
autosomes (on average 1 per 6 Kb on X, and 1 per 11 Kb on
autosomes; Figure S1A), [8]. These average densities correspond
to 12,481 total MREs in the genome, of which only 1 in 91
correspond to the set of CES considered here. Even if we restrict
our attention to chromosome X, only 1 in 28 MREs maps to the
CES set. Therefore, a key question is how functional MREs within
CES are somehow recognized amongst a vast excess of un-utilized
sites. That the MSL complex targets only a fraction of potential
MRE sites for initial binding is a characteristic it shares with many
sequence-specific binding factors whose predicted target motifs are
often in vast excess to the sites actually utilized [16,17]. Here, we
investigate whether chromatin features influence binding site
selection, using the MSL complex and a large compendium of
genome-wide ChIP-chip profiles generated by the NHGRI
modENCODE project as a model [18]. Our results support a
model in which active chromatin composition and intrinsic GC
content help define the initial binding sites of the MSL complex.
Results
An active chromatin context is predictive of functional
MREs
To search for chromatin features that can distinguish functional
MREs from those that do not recruit MSL complex (i.e., non-
functional MREs), we defined five classes of MREs in the
Drosophila genome. The first set consists of 137 MREs that were
experimentally defined by MSL complex binding [8], as discussed
above. We called this set ‘‘Functional MREs’’. The remaining four
sets of 150 sequences each consist of the MREs that have the best
consensus motif matches on either X or a control autosomal arm
(2L) (‘‘Best on X’’ and ‘‘Best on 2L’’ respectively), and 150 MREs
chosen at random from either X or 2L (‘‘Random X’’ and
‘‘Random 2L’’ respectively). We note that, in general, functional
MREs display a broad range of motif binding specificity rather
than being the best matches to the MRE consensus motif (Figure
S1B). The result of this analysis is not affected by the choice of
chromosome arm or the choice of random MREs (data not
shown).
In each of the five classes of MREs, their locations are
distributed along the length of the chromosome arm with no
obvious clustering (Figure S1C). Within each set of sequences, we
calculated the average profiles of various chromatin marks
mapped by the modENCODE Drosophila Chromatin Consor-
tium using genome-wide ChIP-chip. The average ChIP enrich-
ment profiles for 10 kb regions centered around the motif in two
male cell lines (S2 and BG3) are shown in Figure 1B–1C. We
found that a number of chromatin marks associated with active
transcription are strikingly enriched near functional MREs in
CES, and not in the best or random MRE classes on X or
autosomes. These include RNA pol II, H3K36me3, H3K9ac, and
H2B-ubiquitin. In addition, functional sites are relatively depleted
for core histone H4 and linker histone H1. Consistent binding of
the sequence-dependent GAGA factor [19] across categories
serves as an important control to demonstrate that GA-rich
elements are broadly represented in each group of MREs. Another
notable feature of these profiles is the enhancement of H4K16ac
on the X chromosome as a whole [20–22], with additional
enrichment of H4K16ac on true CES (Figure 1B–1C). Since
enrichment of H4K16 acetylation is a known consequence of MSL
targeting, we proceeded to ask whether the observed difference in
chromatin context for other chromatin marks at CES might
simply be a consequence of MSL binding rather than a
contributing factor.
Predictive chromatin marks are independent of MSL
binding
To test whether the observed difference in chromatin context at
CES is a consequence of MSL binding rather than a contributing
factor, we examined the profiles of the same subset of chromatin
marks in female Kc cells. Interestingly, we found that the set of
marks that correlates with MRE function in male S2 cells were
likewise informative in female Kc cells, in the absence of MSL
complex (Figure 1D). The enrichment of H4K16 acetylation on
the male X is notably less pronounced in female Kc cells lacking
MSL complex. Still, this mark is enriched over functional MREs,
consistent with previous observations of MSL-independent
H4K16 acetylation at active genes on all chromosomes in males
and females [21,22]. Most strikingly, H3K36me3 and JIL-1, are
enriched in functional MREs in both male and female cells,
suggesting that these marks are independent of MSL binding at
CES.
We also examined MREs for intrinsic sequence composition to
search for correlations with function (Figure 1E). Surprisingly, we
found a marked elevation of GC content in the 10 Kb flanking
region surrounding functional MREs, coupled with a decrease in
GC content in the 1 Kb nearest the functional MREs. Taken
together, our results support a model in which local sequence
characteristics and the active chromatin context of functional
MREs may facilitate their initial selection.
Next, we wanted to directly test the potential of MREs in an
active chromatin environment in females to recruit MSL complex.
The key female sex determination protein, SXL, represses dosage
compensation by inhibiting MSL2 translation [23,24]. Loss of
SXL results in the expression, stabilization, and targeting of the
Author Summary
The genomes of complex organisms encompass hundreds
of millions of base pairs of DNA, and regulatory molecules
must distinguish specific targets within this vast landscape.
In general, regulatory factors find target genes through
sequence-specific interactions with the underlying DNA.
However, sequence-specific factors typically bind only a
fraction of the candidate genomic regions containing their
specific target sequence motif. Here we identify potential
roles for chromatin environment and flanking sequence
composition in helping regulatory factors find their
appropriate binding sites, using targeting of the Drosoph-
ila dosage compensation complex as a model. The initial
stage of dosage compensation involves binding of the
Male Specific Lethal (MSL) complex to a sequence motif
called the MSL recognition element [1]. Using data from a
large chromatin mapping effort (the modENCODE project),
we successfully identify an active chromatin environment
as predictive of selective MRE binding by the MSL
complex. Our study provides a framework for using
genome-wide datasets to analyze and predict functional
protein–DNA binding site selection.
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RNA interference (RNAi) in Kc cells [26]. Upon treatment, we
observed a general, MSL2-dependent increase in transcription
from the female X chromosomes, consistent with a partial
induction of dosage compensation (Figure 2A–2B). The increase
in X-linked gene expression did not reach the maximum
theoretical amount for perfect compensation (log22=1), consistent
with observations that MSL-independent ploidy effects can also
contribute to overall compensation [27,28].
The induction of MSL complex in Kc cells allowed us to ask
whether ectopic MSL complex in female cells recognized the
same functional subset of MREs on X as in male cells, by
examining the distribution of H4K16 acetylation as a mark of
MSL function. We found that Sxl RNAi induces high levels of
this modification preferentially at the same MREs that are
functional in males (Figure 2C), supporting the idea that MSL
complex recognizes MREs in an active chromatin context. Our
findings with MSL complex parallel recent results for the heat
shock transcription factor HSF [29], suggesting that sequence-
specific DNA binding factors may generally utilize chromatin
context to facilitate selective targeting within a complex euka-
ryotic genome.
Figure 1. Active chromatin context and elevated GC content are associated with functional MSL recognition elements (MREs) on
the X chromosome, independent of MSL binding. (A) The sequence motif for the MRE. (B–D) The average enrichment of various chromatin
modifications or chromatin-binding proteins around (+/25 kb) the functional and non-functional MREs is visualized using a heat map in each of three
Drosophila cell lines: S2 in panel B; BG3 in panel C; and Kc in panel D. (E) A heat map showing the average GC content around each class of MREs. The
data were obtained from genome-wide ChIP-chip profiles generated as part of the modENCODE project. Many active marks are broadly enriched
around functional MREs in both male and female cell lines, suggesting that active chromatin is strongly associated with functional MREs independent
of MSL binding. See also Figures S1 and S2.
doi:10.1371/journal.pgen.1002646.g001
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of functional MREs
Since specific chromatin marks are enriched near MREs that
are utilized compared with those that are not, we next asked
whether these marks provide enough information, either individ-
ually or in combination, to explain the MSL entry site binding
pattern on X. To address this question, we systematically
investigated the predictive power of the chromatin marks for
functional MREs in Kc cells, which have the potential for MSL
targeting but do not express the MSL complex. We asked whether
we could build a simple prediction model based on individual or a
combinations of chromatin features in Kc cells that would
distinguish functional MREs from non-functional ones in male
S2 and BG3 cells, where MSL complex is expressed.
We first tested whether individual chromatin features could
discriminate functional MREs from non-functional ones. A
chromatin feature is defined by its average ChIP enrichment
within the 10 kb region surrounding each MRE. In addition, we
defined two features to represent the average GC content near the
MRE (center 1 kb) or in its flanking regions (10 kb excluding the
center 1 kb). To test whether individual or combinations of
features could distinguish the functional MREs from the non-
functional ones, we used support vector machine (SVM), a
classification algorithm demonstrated to have excellent perfor-
mance in a wide range of problems [30,31]. Briefly, the set of
ChIP enrichment at each MRE is treated as a feature vector of
that MRE. Given a set of training samples, SVM calculates an
optimal hyperplane that can separate non-functional MREs from
functional MREs in the feature space. Here we used a SVM with a
radial basis kernel that is implemented in the R package e1071
(See Methods and Materials). To accurately estimate predictive
power, and to avoid the potential bias due to using the same set of
CES and non-functional MRE genomic locations in S2, BG3 and
Kc cell lines, we evaluated the predictive power of a feature using
10-fold cross-validation. In this scheme, we withhold a random
10% of the MREs, build a model based on the remaining 90%,
measure how well the model predicted the functionality of the
withheld MREs, and repeat this process multiple times to obtain
the average performance. The cross-validation result is presented
using a standard measure called the Area Under Curve (AUC) of
Receiver Operating Characteristic [32] curve. The ROC curve
(examples are shown in Figure 3C) quantifies the sensitivity and
specificity of classification by estimating true and false positive
rates over all threshold values, and the AUC summarizes the curve
with a single number. A random predictor receives an AUC of 0.5,
and a perfect predictor achieves an AUC of 1 [32].
By comparing the AUC of each individual chromatin feature in
Kc, S2 and BG3 cells, we observed that many active chromatin
marks could distinguish functional from non-functional MREs
(Figure 3A). Among all the features tested, H3K36me3 was the
best predictor in all three cell lines (mean AUC of 0.884), followed
by JIL-1 (mean AUC of 0.864). Interestingly, we had previously
speculated that H3K36me3 might be involved, based on MSL
affinity for this mark in active genes [8,12,14]. Since H3K36me3
Figure 2. Ectopic upregulation of MSL2 by Sxl RNAi treatment induces dosage compensation of X-linked genes in female Kc cells by
preferentially targeting MREs in an active chromatin context. (A) Distribution of gene expression ratios after Sxl knockdown in X
chromosome and autosomes compared to control. The y-axis (density) represents the scaled proportion of the number of genes for a given log2
expression ratio (x-axis). Repression of Sxl leads to ectopic expression of MSL2, which results in dosage compensation of the X chromosome. (B)
Distribution of gene expression ratios after Sxl and MSL2 double knockdown for X chromosome and autosomes compared to control. In the absence
of functional MSL2, no dosage compensation is observed. (C) A heat map showing the average enrichment of H4K16 acetylation (H4K16ac) around
(+/25 kb) the functional and non-functional MREs in control (GFP) and after two independent Sxl RNAi knockdowns. The gene expression data in
panels A and B are based on the same cells as replicate 1 in the heat map.
doi:10.1371/journal.pgen.1002646.g002
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MSL binding, they could prime functional MREs for sequence-
specific MSL binding, or be coincident with true causative factors.
Nearly all putative CES in Kc cells are embedded in a chromatin
environment enriched for H3K36me3 (Figure 3B), however, we
previously determined that when H3K36me3 is depleted, there are
still enough features for the MSL complex to distinguish MREs [12].
Since no single feature may be sufficient to drive MSL recognition,
we next asked whether combinations of marks and local sequence
composition might further improve predictive power for CES.
Predictions utilizing combinations of chromatin marks
and local GC content
On average, the GC content of CES is similar to the random or
best MREs in the 1 Kb of sequence immediately surrounding the
motif, but the GC content consistently rises in flanking sequences,
to produce a distinctive average profile (Figure 1E). Examination
of the individual heatmaps confirms that this is a broadly
consistent characteristic of CES (Figure S2). We found that the
relative GC content in D. melanogaster is elevated in genes
compared to intergenic sequence (44% vs. 41%) [33] so it is not
surprising to see this characteristic in conjunction with the active
gene clusters where CES are found. However, the distinctive shape
of the profile, with low GC immediately surrounding the CES, is
unexpected and not seen with autosomal MREs, even when
associated with H3K36me3 and thus presumably analogous active
gene clusters (Figure S2). The significance of this intrinsic feature
clearly merits future experimental analysis. However, GC profile
alone does not appear to provide enough information to predict
functional MREs with high accuracy (Figure 3C).
To search for combinatorial marks that might distinguish
functional MREs, we compared the predictive power of the SVM
generated using every possible combination of features in our
dataset (Figure S3A–S3B). We found that the best individual
features (H3K36me3 and JIL-1) performed very well, similarly to
the best combinations of features when SVM trained using Kc
data, and tested on S2 or BG3 data (Figure 3C). There are many
combinations of features that predict functional MREs with high
accuracy. In general, the best performing combinations included
the following: (1) H3K36me3 or JIL-1; (2) H2B-ubiq or H3K9ac;
(3) a core histone; and (4) GC content (Figure S3A–S3B). The
excellent performance of this combination is consistent with the
identification of these factors as core features by feature correlation
analysis (Figure S3C).
The cross-validation results are summarized in the ROC plots
in Figure 3C and Figure S3D. Although not perfect, the best
combination separates the functional and non-functional MREs
with high accuracy (mean AUC=0.931), as visualized in principal
component space in Figure 3D. Each MRE can be considered as a
point in multi-dimensions, with each axis as the enrichment level
for a mark; to show the data in two-dimensions, we define new
axes, called principal components, which are combinations of the
original variables satisfying certain desirable properties. We can
indeed observe a good separation of the functional from non-
functional MREs in this view (Figure 3D).
Genome-wide prediction of functional MREs
The analyses presented so far focused on only a subset of clearly
functional and non-functional MREs. This allowed us to
effectively identify chromatin features that can distinguish
functional MREs from non-functional ones, and to build a
predictive SVM model for functional MREs. Here we extend our
analysis to test whether our model could accurately select
additional functional MREs genome-wide. We trained an SVM
model with Kc cell chromatin features and then tested its ability to
eliminate non-functional MREs on autosomes and chromosome X
using S2 data. The SVM algorithm selects the decision threshold
that optimally separates functional from non-functional MREs, as
confirmed in Figure S3E, and the overall AUC of this prediction is
about 0.84 (Figure S3F). We specifically tested different individual
and combinations of features. Using the best combination of
features, our SVM model can eliminate over 75% of candidate
MRE sites on X, and ,85% of candidate sites on autosomes,
while retaining almost all of the functional MREs on the X
chromosome (up to 94%) (Table S2). Almost 10,000 non-
functional sites are eliminated using our model, with retention of
approximately 1600 MREs genome-wide. Approximately half
(763) of those remaining MREs map to the X chromosome but are
not included in the conservative set of 137 CES.
We suspect that the large number of remaining MREs on the X
chromosome indicates that there may be more true MSL binding
sites than the set of 137 CES we used in this study. Therefore, we
asked how many of these additional 763 MREs overlap with
previously mapped MSL binding sites identified by MSL3 ChIP-
seq [8]. Of the 763 SVM-predicted functional MREs on X, 503
overlapped with an MSL binding site (Figure 3E). This suggests
that the actual false positive rate on the X chromosome may be as
low as 260/3343=7.8%. This is slightly lower than the false
positive rates for the autosomes (895/8144=11%) (Table S2),
likely due to the fact that even though most strong peaks identified
in the MSL3 ChIP-seq data with stringent criteria are CES [8],
some may be sites to which MSL complex spreads.
Increased lability of nucleosomes at chromatin entry sites
correlates with MSL binding
In addition to enrichment for marks associated with active
genes, we also saw relative depletion of histone H1 over functional
MREs (Figure 1), and, from previous work, depletion of H3 and
thus presumably nucleosomes themselves [8,10]. Therefore, we
examined modENCODE data from S2 and Kc cells on the release
of nucleosomes following salt extraction to determine whether
functional MREs are packaged into more labile chromatin when
compared to non-utilized MREs [34]. We found that in male S2
cells functional MREs are depleted for histones in general, and
Figure 3. Chromatin context is predictive of functional MREs. (A) A bar plot showing the performance of individual chromatin features for
distinguishing functional and non-functional MREs using various training and testing schemes. The best features are H3K36me3 and JIL1. H4K16ac
shows strong association with the presence of functional MREs in both male cell lines but much weaker association in female Kc cells, supporting the
known role of H4K16ac as a key consequence of MSL binding. (B) A heat map showing the distribution of the H3K36me3 mark around individual
functional and non-functional MREs on the X chromosome in female Kc cells, ordered by the level of enrichment at the MREs. (C) Sensitivity (y-axis)
and 1 - specificity (x-axis) of prediction using a support vector machine (SVM) are shown using a receiver operator characteristic (ROC) curve. This
indicates that chromatin features in female Kc cells can be used to predict the identity of functional MREs in male S2 cells with high sensitivity (high
true positive rate) and specificity (low false positive rate). (D) A principal component projection of the functional and non-functional MREs based on
the best chromatin features in S2 cells, showing that the two MREs groups can be well-separated. See also Figure S3. (E) A genome browser view that
shows the overlap of SVM-predicted functional MREs and MSL binding sites identified by an independent MSL3 ChIP-seq analysis.
doi:10.1371/journal.pgen.1002646.g003
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in the pellet after high salt extraction (Figure 4), both fractions that
were previously characterized as enriched in regulatory regions
[35]. In addition, the two sets of non-functional MREs on the X
chromosome appeared to have a milder, but discernable increase
in nucleosome lability when compared to the MREs on
autosomes, consistent with the observation that X chromosome
in male S2 cells generally adopts a more open chromatin
conformation [36].
In contrast, CES MREs in female Kc cells exhibit a modest
average decrease in nucleosomal occupancy (Figure 4), but
intriguingly, this appears to be a difference at a subset of sites
rather than the entire set (Figure S4). Notably, the entire X
chromosome in Kc cells does not appear to be packaged in a more
open chromatin state compared to autosomes (Figure 4). We
conclude that strong nucleosome depletion and a more open
chromatin conformation on X are mainly consequences rather
than causes of MSL binding.
JIL-1 kinase enrichment and histone H1 depletion on
active gene bodies of the MSL–bound X chromosome
Once MSL complex identifies the male X, we have proposed
that it spreads to affect the active genes on the chromosome as a
whole [5]. In addition to the core MSL complex consisting of
proteins that are essential in males but not females (MSL1, MSL2,
MSL3, MOF, and MLE), the JIL-1 kinase is known to be enriched
on the male X [37]. JIL-1 is essential in both males and females
and binds interband regions on all chromosomes in both sexes
[38]. Since we observed that JIL-1 is enriched at functional MREs
(Figure 1 and Figure 3A), we tested whether it is also associated
with active gene bodies. We constructed average scaled profiles of
JIL-1 binding (meta-gene profiles) of all genes greater than 2 kb in
length based on the FlyBase dm3 gene annotation [39]. Gene
expression in the three cell lines was determined by RNA-seq data
(Figure S5) [34]. We found that JIL-1 binds active gene bodies,
with a bias towards 39 ends, on all chromosome arms (Figure 5A).
On the male X, this pattern is increased in its intensity above the
level on autosomes and correlates strongly with binding of the
MSL complex since the increased occupancy is not seen on female
X chromosomes (Figure 5B). These results are consistent with
previous polytene immunostaining [37] and ChIP analyses [40].
In contrast to JIL-1, the linker histone H1 shows depletion on
active genes (Figure 5C). Interestingly, in male cells this depletion
is more prominent on X-linked gene bodies than on autosomal
gene bodies, whereas X and autosomes show no obvious difference
in female cells (Figure 5D), consistent with previous polytene
immunostaining results [41]. These two results further underscore
the distinct character of the Drosophila male X chromosome once
MSL complex is bound to active genes.
When examining our modENCODE data, we noticed that
many additional data sets are slightly enriched on the entire X
chromosome compared to autosomes in male S2 cells, but not in
female Kc cells (Figure S6, and Table S3). X-chromosome-wide
enrichment of nucleoporins, Megator and Nup153 have also been
observed in male S2 cells, but not in female Kc cells [42]. These
Figure 4. Increased lability of nucleosomes at chromatin entry sites correlates with MSL binding. Average enrichment profiles of
chromatin properties around MREs are shown for S2 and Kc cells. Nucleosome density and successive salt extracted fractions of MNase-treated
chromatin from S2 and Kc cells were described previously [28]. Profiled chromatin properties comprise nucleosome density (black) and successive salt
extracted fractions of MNase-treated chromatin: low salt (pink, 80 mM NaCl), high salt (blue, 600 mM NaCl), and pellet (green, salt insoluble). The
dashed red lines on each plot indicate the MRE centers. In male S2 cells, nucleosomes are more labile at the MREs on the X chromosome in general,
and nucleosome density is especially low at functional MREs. The relative lability of nucleosomes on the X chromosome is not seen in female Kc cells,
and the extent of nucleosome depletion at functional MREs is less pronounced. See also Figure S4.
doi:10.1371/journal.pgen.1002646.g004
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to X chromatin in the ChIP procedure, because histone H1 shows
the opposite trend. Therefore, these enrichments may be related to
dosage compensation of the male X, either directly, as is the case
for H4K16ac, JIL-1, and possibly RNA pol II, or indirectly, as a
consequence of the more open chromatin environment created by
the dosage compensation mechanism.
MSL1 and H4K16 acetylation are found on virtually all
active X linked genes in male cells
MSL-dependent dosage compensation is thought to be an
organism-wide phenomenon in Drosophila males, excluded from
the germline [43], but otherwise not restricted to particular tissues
or developmental time points. Classical mitotic recombination
experiments support a requirement for MSL proteins throughout
development in dividing tissues [44]. In addition, comparison of
gene expression in males and females demonstrates that the vast
majority of X-linked genes are up-regulated in males [45].
However, stable MSL binding appears to be more restricted than
its functional consequence, H4K16 acetylation [22], so we
wondered whether binding favored particular types of genes. To
examine this, we plotted the chromatin marks and MSL binding
along active X linked genes in S2 cells (.2 Kb long), asking if
clustering might define genes of particular structure, expression
level, or gene ontogeny category (Figure 6). We found that MSL1
and H4K16 acetylation cover the vast majority (86%) of active X
linked genes. Apparent exceptions (green cluster) are interesting as
those genes also lack H3K36me3 (Figure 6) and H2B-ubiquitin
(data not shown), two prominent marks of transcription [18].
While MSL1 and H4K16ac are associated with the bodies of
virtually all active X linked genes in male S2 cells, the MOF
H4K16 histone acetyltransferase was notably absent from a subset
(dark brown cluster at bottom of Figure 6). Most of these genes still
showed limited MOF enrichment around the promoter region, but
not within the gene bodies as is characteristic of MSL complex.
We were unable to identify any feature, such as relative expression
level or chromatin state, that would distinguish these genes from
the genes that showed MOF enrichment.
Since functional MSL chromatin entry sites are also preferen-
tially associated with active gene marks, we asked where CES map
relative to the set of clustered genes on X, indicating the location
of CES by red dots on the gene structures in Figure 6 (H3K36me3
column). Our results demonstrate that CES are located at variable
positions relative to active genes, with a bias towards their 39-ends.
Interestingly, the subset of genes lacking strong MOF binding
within gene bodies also lack nearby entry sites, in agreement with
the observation that MSL binding is strongest in the close vicinity
of mapped chromatin entry sites [10,46].
Figure 5. The bodies of active X-linked genes are enriched for JIL-1 kinase and depleted for histone H1 in S2 but not Kc cell lines.
Each panel shows the average scaled ChIP enrichment profile (meta-gene profile) of active and inactive genes located on X chromosome and
autosomes. (A) JIL-1 in S2 cells, (B) JIL-1 in Kc cells, (C) H1 in S2 cells, and (D) H1 in Kc cells. Notably, JIL-1 is enriched along the gene bodies of X-linked
genes in males, while histone H1 is depleted. See also Figure S5.
doi:10.1371/journal.pgen.1002646.g005
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Genetic, genomic, and biochemical analyses in eukaryotes have
revealed that DNA binding motifs alone are insufficient to explain
the selective occupancy or specificity of regulatory factor function
[16,17]. The number of predicted binding sites is often vastly
greater than the number of sites actually utilized. Therefore, a very
important question in transcriptional regulation is how to identify
additional parameters that must govern accurate binding site
selection.
In this study, we considered the roles of chromatin environment
and flanking sequence composition in selection of functional
binding sites by a sequence-specific protein complex. It is generally
not clear whether the chromatin features that are often observed at
the binding sites of proteins contribute directly to binding
selectivity or are simply a consequence of binding. In the dosage
compensation system of the X chromosome in Drosophila, we had a
unique opportunity to address this question because we can
compare the chromatin environment of MSL binding sites in
female cells, in the absence of the complex, to male cells, where the
functional sites are bound. We also utilized binding data from an
RNAi experiment in which we knocked down a component of the
sex determination pathway in females to induce dosage compen-
sation. Our bioinformatic analysis of a large number of profiles
from the modENCODE project suggests that a pre-existing active
chromatin context plays a critical role in establishing the initial
binding of the MSL complex on the X. We also made the
surprising discovery that GC content in the DNA surrounding
functional binding sites has a characteristic profile.
In summary, our results strongly support a model in which an
active chromatin composition helps define the initial entry sites
selected by the MSL complex (Figure 7). Functional MSL binding
results in increased lability of local nucleosomal composition, and
H4K16 acetylation and JIL-1 binding along the bodies of virtually
all active X-linked genes. Our work provides key insights into the
order of events leading to dosage compensation in Drosophila, and
can also serve as a model for using genome-wide data sets to
understand how sequence-specific factors find their ultimate
targets.
Materials and Methods
modENCODE ChIP-chip data processing
The majority of the ChIP-chip data are from the modENO-
CODE project [18]. Genomic DNA Tiling Arrays v2.0 (Affyme-
trix) were used to hybridize both ChIP and input DNA. We
obtained the log-intensity ratio values (M-values) for all perfect
match (PM) probes: M=log2(ChIP intensity)2log2(input intensi-
Figure 6. MSL1 and H4K16 acetylation are found on virtually all active X linked genes in male S2 cells. The plot shows the positions of
exons, and the regions of enrichment for MSL1, MOF acetyltransferase, H4K16ac, and H3K36me3 along the bodies of active X linked genes. Each row
represents an active gene scaled to the same size. The genes were clustered based on the chromatin features. These profiles show that CES (red dot
on the H3K36me3 map) are located closer to the 39 end in general and are embedded within domains enriched for H3K36me3 as well as MSL1, MOF,
and H4K16ac.
doi:10.1371/journal.pgen.1002646.g006
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of M in each microarray is equal to 0. The smoothed log intensity
ratios were calculated using LOWESS with a smoothing span
corresponding to 500 bp, combining normalized data from two
replicate experiments. All data are publicly accessible online
through the modENCODE project (URL listed in Table S1). Data
analysis was performed in R statistical programming environment
(http://www.r-project.org). For the visualization of the heatmap
(e.g., Figure 1), the +/25 kb region surrounding each MRE was
separated into non-overlapping bins of 200 bp. The smoothed
probe value within each bin is averaged to obtain the enrichment
value for that bin.
Local sequence GC content
The GC content around each nucleotide is defined as the
proportion of G or C in the closest 101 bp (ie, the target
nucleotide, 50 bp upstream and 50 bp downstream). Similar to the
ChIP-chip data, we separated the +/25 kb region surrounding
each MRE into non-overlapping bins of 200 bp. The average GC
content in each bin represents the average of the GC content of
the 200 bp within that bin.
RNAi followed by expression analysis and ChIP–chip
We generated double-stranded RNA (dsRNA) to target GFP
(negative control) or Sxl transcripts (amplicons designed by the
Drosophila RNAi Screening Center (www.flyrnai.org), as described
previously [22]. The following primer sets were utilized to amplify
PCR products to template dsRNA synthesis:
GFP
F5 9-TAATACGACTCACTATAGGGAGAGGTGAGCAA-
GGGCGAGGAGCT-39
R5 9-TAATACGACTCACTATAGGGAGATCTTGAAGT-
TCACCTTGATGCCG-39
Sxl (DRSC21490)
F5 9-TAATACGACTCACTATAGGGAGAGATCACAGC-
CGCTGTCC-39
R5 9-TAATACGACTCACTATAGGGAGATACCGAATT-
AAGAGCAAATAATAA-39
Sxl (DRSC28896)
F5 9-TAATACGACTCACTATAGGGAGACCCTATTCAG-
AGCCATTGGA-39
R5 9-TAATACGACTCACTATAGGGAGAGTTATGGTA-
CGCGGCAGATT-39
For expression analyses, GFP and Sxl DRSC21490 RNAi was
performed in Kc cells using 6-well plates as described [47].
For ChIP-chip, RNAi using GFP, Sxl DRSC 21490, and Sxl
DRSC28896 amplicons in Kc cells was scaled up to T225 flasks
and chromatin preparation, and H4K16ac ChIP was performed
using anti-H4K16ac antibody (Millipore, 07-329) and custom
Nimblegen tiling arrays as described [22].
Kc GFP H4K16ac ChIP-chip datasets were published previ-
ously [22]: Gene Expression Omnibus accession numbers:
GSM372470 (replicate #1) and GSM372471 (replicate #2).
Cross-validation
We used 10-fold cross-validation to estimate the predictive
power of a classification model based on a training dataset (e.g.,
chromatin feature in Kc cells) and a test dataset (e.g., chromatin
feature in S2 cells). Each sample in a dataset is an MRE, a feature
is a histone modification (e.g., H3K36me3) or a chromatin binding
protein (RNA Pol II), and the label for each sample is either
‘‘Functional MRE’’ (positive class) or ‘‘Non-functional MRE’’
Figure 7. Model for binding site selection by a chromatin associated factor. Our results support roles for local chromatin environment and
flanking GC content in discrimination of true target sites of the MSL dosage compensation complex. The model depicts the GC content and active
chromatin marks surrounding MREs in female Kc cells that predict binding by MSL complex in male S2 or BG3 cells (or after MSL induction in female
Kc cells). MREs that do not pre-exist in a favorable environment are not bound by MSL complex and thus are non-functional. Definition of the
favorable chromatin features that pre-exist factor binding may be a general tool, in addition to DNA motif analysis, for prediction of functional
binding sites.
doi:10.1371/journal.pgen.1002646.g007
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distinguish functional from non-functional MREs based on the
chromatin features. In a 10-fold cross-validation, the training data
are randomly divided into 10 equal-sized portions in which the
same proportion of positive and negative samples are preserved in
each portion. In each of the 10 iterations, the data from nine
portions are used to train a predictive model, while the remaining
one portion is used to test the performance of the prediction
model. Performance is measured by true positive rate (sensitivity)
and false positive rate (1-specificity). The tradeoff between true
and false positive rates are often represented by a receiver
operation characteristic curve, and the Area Under the ROC
Curve (AUC) is a measure of the prediction accuracy that takes
into account both sensitivity and specificity of the prediction
model. A random predictor receives an AUC of 0.5, and a perfect
predictor achieves an AUC of 1. Using 10-fold cross-validation, an
AUC is calculated for each fold (one iteration), and the mean and
standard deviation of the 10 AUC values are recorded.
Calculation and visualization of the ROC curves were performed
by the ROCR package [32].
Support vector machine (SVM)
SVM is a supervised classification algorithm that separates two
classes of data based on a set of features [30,31]. In this study, the
set of ChIP enrichment at each MRE is treated as a feature vector
of that MRE. Given a set of feature vectors from functional MREs
and a set of feature vector from non-functional MREs, the SVM
algorithm calculates an optimally-separating hyperplane by
maximizing the distance (called margin) between the hyperplane
and the nearest points from the two classes. This hyperplane
effectively divides the space of feature vectors into two regions, one
for each class, with the idea that the larger margin lowers the error
of the classifier. To make a prediction, the feature vector
corresponding to a MRE from the test set is compared to this
hyperplane to determine on which side of the separating boundary
this sample is located. We used the SVM implementation in the R
package e1071, which is optimized for the radial basis function
kernel and uses an Sequential Minimal Optimization-type
algorithm [48] using default parameters for training the SVM.
ChIP–seq data processing
We used the MSL3-TAP ChIP-seq data from Alekseyenko et al
[8]. The raw sequence reads were aligned to the Drosophila
melanogaster genome assembly dm3 using bowtie with default
options [49]. We only allowed uniquely mapped reads to be
reported. This procedure resulted in 2.8 and 2.4 million mapped
reads for ChIP and input DNA samples. The aligned reads were
then analyzed with SPP [50] to identify ChIP-enriched regions
(FDR threshold of 0.05).
RNA–seq gene expression data
Gene expression level estimates in S2, BG3 and Kc cells were
obtained from the modENCODE project [34]. The expression of
each gene is quantified in terms of RPKM (reads per million reads
per kilobase). The distribution of gene expression in each cell line
was assessed and a cut-off of RPKM=3 was determined to be a
good threshold to separate active vs. inactive genes (Figure S5A).
This definition of active vs. inactive genes was used in the
construction of meta-gene profiles.
Construction of meta-gene profiles
We used the gene annotation from FlyBase [39] to define
transcription start and end sites (TSS and TES respectively). We
only included genes with a minimum length of 2 kb (7,231 of
15,186 genes) to exclude short genes from our analysis. The ChIP
enrichment in the 2 kb region centered on the TSS and TES, as
well as the ChIP enrichment within the gene body scaled to 1 kb,
were calculated and averaged for the active and inactive genes in
X and autosomes. The definitions of active vs. inactive genes were
defined by RNA-seq data.
Accession numbers
All ChIP-chip and RNA-seq data are available from mod-
ENCODE, and the URL for individual datasets is listed in Table
S1. The ChIP-chip and microarray gene expression data
pertaining to the Sxl RNAi experiments are accessible from
GEO (Accession number: GSE34859).
Supporting Information
Figure S1 Distribution of functional and non-functional MREs.
(A) The number of MREs per megabase (Mb) on each major
chromosome arm based on motif detection with different p-value
thresholds. The number of MREs located on the X chromosome is
roughly twice the number of each autosomal chromosome arm. (B)
The distribution of motif detection p-values for each of the classes
of MREs defined in this study. The motif specificity (as
approximated by motif detection p-value) of the functional MREs
at chromatin entry sites (CESs) is similar to other random MREs
on chromosome X and an autosomal arm (chr2L). (C) Histograms
showing the distance between consecutive randomly chosen 137
non-functional MREs (left panel) and 137 functional MREs (right
panel) along the X chromosome. The red dotted lines indicate the
average log2 distance in base pairs between two consecutive
MREs. The mean distances of the functional and non-functional
MREs are not significantly different (t-test), suggesting there is no
significant difference in the distribution and clustering of
functional and non-functional MREs.
(DOC)
Figure S2 Average GC content around different classes of
MREs. (A) The average plot of GC content around chromatin
entry site (CES), autosomal MREs that have H3K36me3
enrichment, and MREs chosen randomly from chromosome 2L.
(B) Heat maps showing the distribution of GC content for the
MREs shown in panel A. It is particularly striking to observe that
even though GC content is generally higher at functional MREs
and non-functional autosomal MREs enriched for H3K36me3,
there is a strong decrease in GC content only at the center of
functional MREs.
(DOC)
Figure S3 Chromatin features are predictive of functional
MREs in both male and female cells. (A–B) AUC of individual
and all possible combinations of chromatin features for predicting
functional MREs based on 10-fold cross-validation. For each
feature or feature set, an SVM model was trained on the
chromatin ChIP-chip data of Kc cells, and the prediction
performance was tested on data from S2 and BG3 cells.
H3K36me3 and JIL-1 are the best individual features, and the
best SVM prediction models use a combination of 4 or 5 features.
The AUC of the best individual, best combination, or all features
are show in brackets. (C) Correlation between every pair of
features using the Kc cells data. (D) ROC curves showing the
ability of various chromatin features to discriminate functional
MREs from non-functional MREs based on 10-fold cross-
validation, where SVM was trained on Kc cells, and the
performance was assessed on data from BG3 cells. (E) The
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functional autosomal MREs when using SVM for genome-wide
prediction of functional MREs. After we train an SVM, we can use
different thresholds (distance to hyperplane) to determine whether
an MRE is functional or not. The default threshold is 0 (i.e., the
best binary classification is achieved using the SVM-determined
hyperplane). (F) The trade-off between true positive rate (defined
as proportion of CES retained) and false positive rate (defined as
proportion of autosomal MRE retained) can be visualized as an
ROC curve. The AUC is about 0.84.
(DOC)
Figure S4 Decreased nucleosome occupancy upon MSL
binding on X chromosome. (A) The average nucleosome
occupancy in functional and non-functional MREs in male S2
cells. There is a strong decrease of nucleosome occupancy in
functional MREs on the X chromosome. (B) The average
nucleosome occupancy in functional and non-functional MREs
in female Kc cells. There is a less pronounced difference in
nucleosome occupancy among different classes of MREs.
Collectively, these observations suggest that decrease in nucleo-
some occupancy is mainly a result of MSL binding on the X
chromosome.
(DOC)
Figure S5 Estimating gene expression activity in S2, BG3 and
Kc cells using RNA-seq, and additional meta-gene profiles. (A)
Distribution of normalized read counts (RPKM) in S2, BG3 and
Kc cell lines. A bimodal distribution of gene expression is
apparent. A threshold of log2(RPKM+1)=2 (ie, RPKM=3) was
chosen as a threshold to distinguish active from inactive genes (red
dotted lines). (B) Meta-gene profiles of JIL-1 and H1 in active and
inactive genes of BG3 cells. (C) Meta-gene profiles of H4K16ac in
active and inactive genes of S2 and Kc cells.
(DOC)
Figure S6 Chromosome-wide enrichment of different histone
marks. There is generally no significant difference between the
enrichment distribution on chromosome X and the autosomes in
female Kc cells. However, there is enrichment of H2B-ubiq and
H3K36me3 and depletion of H1 and H4 in the male S2 and BG3
cell lines, suggesting X chromosome specific enrichment of certain
active histone marks in male cells upon dosage compensation. See
also Table S2.
(DOC)
Table S1 URL of the modENCODE datasets used in this study.
(DOC)
Table S2 The number and proportion of non-functional MREs
eliminated from each chromosome using the best combination of
features, best individual features only (H3K36me3 or JIL-1), or
GC content only. Chromatin features can eliminate over 85% of
the non-functional MREs on autosomes, and over 75% of non-
functional MREs on X. The high proportion of false positives on
the X chromosome indicates that there are likely more true MSL
binding sites than the set of sites we used in this study.
(DOC)
Table S3 Chromosome-wide enrichment of many active
chromatin marks on the male X chromosome compared to
autosomes. The mode of the ChIP enrichment density profile is
calculated for each major chromosome arm in S2, BG3 and Kc
cells. The mode of the X chromosome enrichment is compared to
the average of the modes of autosome enrichment in each sample.
We observe that the mode of enrichment density is similar in all
profiles in Kc cells. In contrast, there is enrichment in many active
chromatin marks on the male X chromosome compared to
autosomes, as well as depletion of core and linker histones on the
male X.
(DOC)
Acknowledgments
We are grateful to Dr. J. Kadonaga for anti-H1 antibodies, Dr. A.
Greenleaf for anti-RNA pol II antibodies, and Dr. C. Wang for critical
reading of the manuscript.
Author Contributions
Conceived and designed the experiments: GHK SCRE VP PJP MIK.
Performed the experiments: AAA MG AP AAG EL TG AM NCR YBS.
Analyzed the data: JWKH SP MYT PVK YLJ PJP. Wrote the paper:
JWKH AAA PJP MIK.
References
1. Amrein H, Axel R (1997) Genes expressed in neurons of adult male Drosophila.
Cell 88: 459–469.
2. Lucchesi JC (2009) The structure-function link of compensated chromatin in
Drosophila. Cur Opin Genet Dev 19: 550–556.
3. Straub T, Becker PB (2011) Transcription modulation chromosome-wide:
universal features and principles of dosage compensation in worms and flies.
Curr Opin Genet Dev 21: 147–153.
4. Georgiev P, Chlamydas S, Akhtar A (2011) Drosophila dosage compensation:
Males are from Mars, females are from Venus. Fly 5: 147–154.
5. Gelbart ME, Kuroda MI (2009) Drosophila dosage compensation: A complex
voyage to the X chromosome. Development 136: 1399–1410.
6. Ivaldi MS, Karam CS, Corces VG (2007) Phosphorylation of histone H3 at
Ser10 facilitates RNA polymerase II release from promoter-proximal pausing in
Drosophila. Genes Dev 21: 2818–2831.
7. Kelley RL, Meller VH, Gordadze PR, Roman G, Davis RL, et al. (1999)
Epigenetic spreading of the Drosophila dosage compensation complex from roX
RNA genes into flanking chromatin. Cell 98: 513–522.
8. Alekseyenko AA, Peng S, Larschan E, Gorchakov AA, Lee OK, et al. (2008) A
sequence motif within chromatin entry sites directs MSL establishment on the
Drosophila X chromosome. Cell 134: 599–609.
9. Lyman LM, Copps K, Rastelli L, Kelley RL, Kuroda MI (1997) Drosophila
male-specific lethal-2 protein: structure/function analysis and dependence on
MSL-1 for chromosome association. Genetics 147: 1743–1753.
10. Straub T, Grimaud C, Gilfillan GD, Mitterweger A, Becker PB (2008) The
chromosomal high-affinity binding sites for the Drosophila dosage compensation
complex. PLoS Genet 4: e1000302. doi:10.1371/journal.pgen.1000302.
11. Alekseyenko AA, Larschan E, Lai WR, Park PJ, Kuroda MI (2006) High-
resolution ChIP-chip analysis reveals that the Drosophila MSL complex
selectively identifies active genes on the male X chromosome. Genes Dev 20:
848–857.
12. Larschan E, Alekseyenko AA, Gortchakov AA, Peng S, Li B, et al. (2007) MSL
complex is attracted to genes marked by H3K36 trimethylation using a
sequence-independent mechanism. Mol Cell 28: 121–133.
13. Kind J, Akhtar A (2007) Cotranscriptional recruitment of the dosage
compensation complex to X-linked target genes. Genes Dev 21: 2030–2040.
14. Bell O, Conrad T, Kind J, Wirbelauer C, Akhtar A, et al. (2008) Transcription-
coupled methylation of histone H3 at lysine 36 regulates dosage compensation
by enhancing recruitment of the MSL complex in Drosophila melanogaster. Mol
Cell Biol 28: 3401–3409.
15. Gorchakov AA, Alekseyenko AA, Kharchenko P, Park PJ, Kuroda MI (2009)
Long-range spreading of dosage compensation in Drosophila captures
transcribed autosomal genes inserted on X. Genes Dev 23: 2266–2271.
16. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, et al. (2005) Chromosome-
wide mapping of estrogen receptor binding reveals long-range regulation
requiring the forkhead protein FoxA1. Cell 122: 33–43.
17. Sekinger EA, Moqtaderi Z, Struhl K (2005) Intrinsic histone-DNA interactions
and low nucleosome density are important for preferential accessibility of
promoter regions in yeast. Mol Cell 18: 735–748.
18. Kharchenko PV, Alekseyenko AA, Schwartz YB, Minoda A, Riddle NC, et al.
(2011) Comprehensive analysis of the chromatin landscape in Drosophila
melanogaster. Nature 471: 480–485.
19. Granok H, Leibovitch BA, Shaffer CD, Elgin SC (1995) Chromatin. Ga-ga over
GAGA factor. Curr Biol 5: 238–241.
20. Turner BM, Birley AJ, Lavender J (1992) Histone H4 isoforms acetylated at
specific lysine residues define individual chromosomes and chromatin domains
in Drosophila polytene nuclei. Cell 69: 375–384.
Epigenetic Targeting of Dosage Compensation
PLoS Genetics | www.plosgenetics.org 12 April 2012 | Volume 8 | Issue 4 | e100264621. Kind J, Vaquerizas JM, Gebhardt P, Gentzel M, Luscombe NM, et al. (2008)
Genome-wide analysis reveals MOF as a key regulator of dosage compensation
and gene expression in Drosophila. Cell 133: 813–828.
22. Gelbart ME, Larschan E, Peng S, Park PJ, Kuroda MI (2009) Drosophila MSL
complex globally acetylates H4K16 on the male X chromosome for dosage
compensation. Nat Struct Mol Biol 16: 825–832.
23. Kelley RL, Wang J, Bell L, Kuroda MI (1997) Sex lethal controls dosage
compensation in Drosophila by a non-splicing mechanism. Nature 387:
195–199.
24. Gebauer F, Grskovic M, Hentze MW (2003) Drosophila sex-lethal inhibits the
stable association of the 40S ribosomal subunit with msl-2 mRNA. Mol Cell 11:
1397–1404.
25. Gorman M, Kuroda MI, Baker BS (1993) Regulation of the sex-specific binding
of the maleless dosage compensation protein to the male X chromosome in
Drosophila. Cell 72: 39–49.
26. Duncan K, Grskovic M, Strein C, Beckmann K, Niggeweg R, et al. (2006) Sex-
lethal imparts a sex-specific function to UNR by recruiting it to the msl-2 mRNA
39 UTR: translational repression for dosage compensation. Genes Dev 20:
368–379.
27. Zhang Y, Malone JH, Powell SK, Periwal V, Spana E, et al. (2010) Expression
in aneuploid Drosophila S2 cells. PLoS Biol 8: e1000320. doi:10.1371/
journal.pbio.1000320.
28. Stenberg P, Larsson J (2011) Buffering and the evolution of chromosome-wide
gene regulation. Chromosoma 120: 213–225.
29. Guertin MJ, Lis JT (2010) Chromatin landscape dictates HSF binding to target
DNA elements. PLoS Genet 6: e1001114. doi:10.1371/journal.pgen.1001114.
30. Cortes C, Vapnik V (1995) Support-Vector Networks. Mach Learn 20:
273–297.
31. Shawe-Taylor J, Cristianini N Support Vector Machine and other kernel-based
methods: Cambridge University Press.
32. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: Visualizing
classifier performance in R. Bioinformatics 21: 3940–3941.
33. Tweedie S, Ashburner M, Falls K, Leyland P, McQuilton P, et al. (2009)
FlyBase: Enhancing Drosophila Gene Ontology annotations. Nucleic Acids Res
37: D555–559.
34. modENCODE Consortium, Roy S, Ernst J, Kharchenko PV, Kheradpour P,
et al. (2010) Identification of functional elements and regulatory circuits by
Drosophila modENCODE. Science 330: 1787–1797.
35. Henikoff S, Henikoff JG, Sakai A, Loeb GB, Ahmad K (2009) Genome-wide
profiling of salt fractions maps physical properties of chromatin. Genome Res
19: 460–469.
36. Bell O, Schwaiger M, Oakeley EJ, Lienert F, Beisel C, et al. (2010) Accessibility
of the Drosophila genome discriminates PcG repression, H4K16 acetylation and
replication timing. Nat Struct Mol Biol 17: 894–900.
37. Jin Y, Wang Y, Walker DL, Dong H, Conley C, et al. (1999) JIL-1: a novel
chromosomal tandem kinase implicated in transcriptional regulation in
Drosophila. Mol Cell 4: 129–135.
38. Wang Y, Zhang W, Jin Y, Johansen J, Johansen KM (2001) The JIL-1 tandem
kinase mediates histone H3 phosphorylation and is required for maintenance of
chromatin structure in Drosophila. Cell 105: 433–443.
39. Drysdale RA, Crosby MA (2005) FlyBase: Genes and gene models. Nucleic
Acids Res 33: D390–395.
40. Regnard C, Straub T, Mitterweger A, Dahlsveen IK, Fabian V, et al. (2011)
Global analysis of the relationship between JIL-1 kinase and transcription. PLoS
Genet 7: e1001327. doi:10.1371/journal.pgen.1001327.
41. Corona DF, Siriaco G, Armstrong JA, Snarskaya N, McClymont SA, et al.
(2007) ISWI regulates higher-order chromatin structure and histone H1
assembly in vivo. PLoS Biol 5: e232. doi:10.1371/journal.pbio.0050232.
42. Vaquerizas JM, Suyama R, Kind J, Miura K, Luscombe NM, et al. (2010)
Nuclear pore proteins nup153 and megator define transcriptionally active
regions in the Drosophila genome. PLoS Genet 6: e1000846. doi:10.1371/
journal.pgen.1000846.
43. Bachiller D, Sanchez L (1986) Mutations affecting dosage compensation in
Drosophila melanogaster: effects in the germline. Dev Biol 118: 379–384.
44. Belote JM (1983) Male-Specific Lethal Mutations of DROSOPHILA MELA-
NOGASTER. II. Parameters of Gene Action during Male Development.
Genetics 105: 881–896.
45. Gupta V, Parisi M, Sturgill D, Nuttall R, Doctolero M, et al. (2006) Global
analysis of X-chromosome dosage compensation. J Biol 5: 3.
46. Sural TH, Peng S, Li B, Workman JL, Park PJ, et al. (2008) The MSL3
chromodomain directs a key targeting step for dosage compensation of the
Drosophila melanogaster X chromosome. Nat Struct Mol Biol 15: 1318–1325.
47. Hamada FN, Park PJ, Gordadze PR, Kuroda MI (2005) Global regulation of X
chromosomal genes by the MSL complex in Drosophila melanogaster. Genes
Dev 19: 2289–2294.
48. Fan R-E, Chen P-H, Lin C-J (2005) Working set selection using second order
information for training SVM. J Mach Learn Res 6: 1889–1918.
49. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome. Genome Biol
10: R25.
50. Kharchenko PV, Tolstorukov MY, Park PJ (2008) Design and analysis of ChIP-
seq experiments for DNA-binding proteins. Nature Biotechnol 26: 1351–1359.
Epigenetic Targeting of Dosage Compensation
PLoS Genetics | www.plosgenetics.org 13 April 2012 | Volume 8 | Issue 4 | e1002646